Providing more than 200 human primary cell types
Lonza BioScience provides research tools including primary cells, media and reagents, to support the preclinical and clinical pharmaceutical work flow for drug discovery and ADMETox to better understand the pharmacokentics and metabolism of new compounds. Our integrated portfolio including liver, kidney, skin, lung, and neural cells allows for the development of the next generation of predictive in vitro ADMETox solutions.